» Articles » PMID: 12383205

C-reactive Protein-mediated Phagocytosis and Phospholipase D Signalling Through the High-affinity Receptor for Immunoglobulin G (FcgammaRI)

Overview
Journal Immunology
Date 2002 Oct 18
PMID 12383205
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

C-reactive protein (CRP) is the prototypic acute-phase protein in man which performs innate immune functions. CRP-mediated phagocytosis may be indirect, through activation of complement and complement receptors, or direct, through receptors for the Fc portion of immunoglobulin G (IgG; FcgammaRs) or even a putative CRP-specific receptor. No strong evidence has been shown to indicate which receptors may be responsible for phagocytosis or signalling responses. Using BIAcore technology, we confirm that CRP binds directly to the extracellular portion of FcgammaRI with a threefold higher affinity than IgG (KD = 0.81 x 10-9 m). Binding is Ca2+ dependent and is inhibited by IgG1 but not by phosphorylcholine (PC). CRP opsonization (using CRP concentrations within the normal human serum range) of PC-conjugated sheep erythrocytes increased phagocytosis of these particles by COS-7 cells transfected with FcgammaRI-II chimaera or FcgammaRI/gamma-chain. Interferon-gamma-treated U937 cells, which signal through FcgammaRI to activate phospholipase D (PLD) in response to cross-linked IgG, were also activated by CRP without any requirement for further cross-linking. These studies indicate that CRP is capable of binding to and cross-linking FcgammaRI thereby resulting in PLD activation and increased phagocytosis. Uptake by FcgammaRI has been reported to promote various acquired immune responses suggesting that CRP could act in a similar way.

Citing Articles

A Comprehensive Review of Fc Gamma Receptors and Their Role in Systemic Lupus Erythematosus.

Sepulveda-Delgado J, Llorente L, Hernandez-Dono S Int J Mol Sci. 2025; 26(5).

PMID: 40076476 PMC: 11899777. DOI: 10.3390/ijms26051851.


The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity.

Caratelli S, De Paolis F, Silvestris D, Baldari S, Salvatori I, Tullo A Exp Hematol Oncol. 2025; 14(1):17.

PMID: 39962623 PMC: 11834217. DOI: 10.1186/s40164-025-00601-2.


Structural basis for surface activation of the classical complement cascade by the short pentraxin C-reactive protein.

Noone D, Isendoorn M, Hamers S, Keizer M, Wulffele J, van der Velden T Proc Natl Acad Sci U S A. 2024; 121(37):e2404542121.

PMID: 39240968 PMC: 11406272. DOI: 10.1073/pnas.2404542121.


Advances in proteomics: characterization of the innate immune system after birth and during inflammation.

Bennike T Front Immunol. 2023; 14:1254948.

PMID: 37868984 PMC: 10587584. DOI: 10.3389/fimmu.2023.1254948.


Fc receptors act as innate immune receptors during infection?.

Laassili C, Ben El Hend F, Benzidane R, Oumeslakht L, Aziz A, El Fatimy R Front Immunol. 2023; 14:1188497.

PMID: 37564652 PMC: 10410254. DOI: 10.3389/fimmu.2023.1188497.


References
1.
Sorensen I, Andersen O, Nielsen E, Svehag S . Native human serum amyloid P component is a single pentamer. Scand J Immunol. 1995; 41(3):263-7. DOI: 10.1111/j.1365-3083.1995.tb03562.x. View

2.
Davis W, Harrison P, Hutchinson M, Allen J . Two distinct regions of FC gamma RI initiate separate signalling pathways involved in endocytosis and phagocytosis. EMBO J. 1995; 14(3):432-41. PMC: 398101. DOI: 10.1002/j.1460-2075.1995.tb07019.x. View

3.
INDIK Z, Park J, Hunter S, Schreiber A . Structure/function relationships of Fc gamma receptors in phagocytosis. Semin Immunol. 1995; 7(1):45-54. DOI: 10.1016/1044-5323(95)90007-1. View

4.
Marnell L, Mold C, Volzer M, Burlingame R, Du Clos T . C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol. 1995; 155(4):2185-93. View

5.
Heijnen I, van Vugt M, Fanger N, Graziano R, De Wit T, Hofhuis F . Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest. 1996; 97(2):331-8. PMC: 507022. DOI: 10.1172/JCI118420. View